FDA Approved: MOVANTIK — Supplemental Application (RedHill Biopharma Ltd)

View source ↗

Summary

FDA approved a supplemental application for MOVANTIK (naloxegol oxalate) submitted by RedHill Biopharma Ltd, primarily affecting labeling changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• MOVANTIK (Naloxegol oxalate)

Snippet

SUPPL AP for MOVANTIK (NALOXEGOL OXALATE)